[
1. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland: World Health Organization; 1999:31–3.
]Search in Google Scholar
[
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.10.1001/jama.285.19.2486
]Search in Google Scholar
[
3. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels, Belgium: International Diabetes Federation; 2006.
]Search in Google Scholar
[
4. Bluher M. Adipose tissue dysfunction in obesity. ExpClin Endocrinol Diabetes. 2009; 117:241-50.10.1055/s-0029-1192044
]Search in Google Scholar
[
5. Karastegiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Molecular and Cellular Endocrinology. 2010;318:1784-92.
]Search in Google Scholar
[
6. Leal VO, Mafra D. Adipokines in obesity. Clin Chim Acta. 2013;419:87–94.10.1016/j.cca.2013.02.003
]Search in Google Scholar
[
7. Pereira S, Alvarez-Leite J. Adipokines: biological functions and metabolically healthy obese profile. J Receptor Ligand Channel Res. 2014;7:15-25.10.2147/JRLCR.S36060
]Search in Google Scholar
[
8. Kwiterovich PO. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol. 2002;90:30–47.10.1016/S0002-9149(02)02749-2
]Search in Google Scholar
[
9. Muniyappa R, Lee S, Chen H, Quon, MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008, 294:15-26.10.1152/ajpendo.00645.200717957034
]Search in Google Scholar
[
10. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MBet al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000, 23:57-63.10.2337/diacare.23.1.5710857969
]Search in Google Scholar
[
11. Miller WG, Thienpont LM, Van Uytfanghe K, Clark PM, Lindstedt P, Nilsson G et al. Insulin Standardization Work Group: Toward standardization of insulin immunoassays. Clin Chem. 2009, 55:1011-8.10.1373/clinchem.2008.11838019325009
]Search in Google Scholar
[
12. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.
]Search in Google Scholar
[
13. Liu A, Reaven GM. Is measurement of non-HDL cholesterol an effective way to identify the metabolic syndrome? Nutr Metab Cardiovasc Dis. 2013;23:1122–7.
]Search in Google Scholar
[
14. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis. 2010;9(1):1-9.10.1186/1476-511X-9-85293366520712907
]Search in Google Scholar
[
15. Thomas G, Pickering, MD et al. Recomendation for blood pressure measurment in humans and experimental animals, Hypertension, 2004;45:142.
]Search in Google Scholar
[
16. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Matthews et al. Diabetologia. 1985;28(7):412-9.10.1007/BF002808833899825
]Search in Google Scholar
[
17. Matthews DR, Hosker JP, Rudenski AS еt al. Homeostasis model assessment: insulin resistance and beta-cells function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-41.10.1007/BF002808833899825
]Search in Google Scholar
[
18. Da luz PL, Cesena FH, Favarato D, Cerqueira ES. Comparison of serumlipid values in patients with coronary artery disease at <50, 50 to 59, 60 to 69, and >70 years of age. Am J Cardiol. 2005;96:1640-3.10.1016/j.amjcard.2005.07.08016360350
]Search in Google Scholar
[
19. Ke Wan, Jianxun Zhao, Hao Huang et al. The Association between Triglyceride/High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality in Acute Coronary Syndrome after Coronary Revascularization. 2015 Apr 16;10(4):e0123521.10.1371/journal.pone.0123521439984025880982
]Search in Google Scholar
[
20. Thomas G, Pickering MD et al. Recomendation for blood pressure measurment in humans and experimental animals. Hypertension. 2004;45:142.
]Search in Google Scholar
[
21. Matthews DR, Hosker JP, Rudenski AS еt al. Homeostasis model assessment: insulin resistance and beta-cells function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-41.10.1007/BF00280883
]Search in Google Scholar
[
22. Ke Wan, Jianxun Zhao, Hao Huang et al. The Association between Triglyceride/High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality in Acute Coronary Syndrome after Coronary Revascularization. 2015 Apr 16;10(4):e0123521.10.1371/journal.pone.0123521
]Search in Google Scholar
[
23. Koleva D, Orbetzova M. Metabolic and Atherogenic Parameters in Women with Metabolic Syndrome and MetabolicallyHealthy Overweight/Obese Women. Endocrinologia. 2017;2:81-6.
]Search in Google Scholar
[
24. Naidenova, G. The АРО B/АРО A1 ratio in determinig the balance between plasma proatherogenic and anti-atherogenic lipoproteins. Medinfo. 2014;1. (In Bulgarian)
]Search in Google Scholar
[
25. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are Insulin Resistant. Ann Internal Med. 2003;139(10):802-9.10.7326/0003-4819-139-10-200311180-0000714623617
]Search in Google Scholar
[
26. Li C, Ford E, Meng Y, Mokdad A and Reaven G. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovascdiabetol. 2008; 7:4-10.
]Search in Google Scholar
[
27. Sumner AE, Harman JL, Buxbaum SG, Miller BV, Tambay AV, Wyatt SB et al. The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: an analysis of Jackson Heart Study. MetabSyndrRelatDisord, 2010, 8:511-4.10.1089/met.2010.0028312556420715971
]Search in Google Scholar
[
28. Jui-Chiang K, Lai N, Chang J, and Koo M. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovasc Diabetol. 2011;10:93.10.1186/1475-2840-10-93322445422004541
]Search in Google Scholar
[
29. Simi A, Tsakiri N, Wang P, Rothwell NJ. Interleukin-1 and inflammatory neurodegeneration. Biochemical Society Transactions. 2007;35(5):1122–6.10.1042/BST035112217956293
]Search in Google Scholar
[
30. Fried SK, Bunkin DA & Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 1998;83:847–50.
]Search in Google Scholar
[
31. Kang YE, Kim JM, Joung KH et al. The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-Associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS ONE. 2016;11:e0154003.10.1371/journal.pone.0154003483962027101398
]Search in Google Scholar
[
32. Winkler G, Kiss S, Keszthelyi L, et al. Expression of tumor necrosis factor (TNF)-alphaprotein in the subcutaneous and visceral adipose tissue incorrelation with adipocyte cell volume, serum TNF-alpha, soluble serumTNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2000;149:129–35.
]Search in Google Scholar
[
33. Festa A, D‘Agostino R, Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42–7.10.1161/01.CIR.102.1.42
]Search in Google Scholar
